qPCR Instruments Innovation and Product Evolution

Who are the qPCR Instruments Market Top Companies and What are Their Offerings?

The smarter way to monitor the qPCR Instruments Market starts here - Download Sample.

What are the Recent Developments in the qPCR Instruments Market?

• In April 2025, for the detection of hypermutated phenotype associated with mutations in POLD1 and POLE in endometrial cancer, Idylla, which is a fully automated, real-time quantitative polymerase chain reaction (qPCR) assay, was launched by Biocartis, where it detects 1 mutation in the POLD1 gene and 17 point mutations in the POLE gene.
• In September 2024, an automated, high-throughput qPCR solution, the SmartChip ND™ Real-Time PCR System, for research-use-only (RUO) monitoring antimicrobial resistance (AMR) and ensuring environmental safety and sustainability, was launched by Takara Bio USA, Inc.

qPCR Instruments Market Value Chain Analysis

R&D

• The R&D of the qPCR instruments focuses on the integration of vapor chamber cooling technology, extreme multiplexing, and AI-driven automated data analysis.
• Key players: Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics.

Clinical Trials and Regulatory Approvals

• The analytical sensitivity, reproducibility, and clinical specificity are evaluated in the clinical trials and regulatory approval of the qPCR instruments.
• Key players: Bio-Rad Laboratories, Roche Diagnostics, Cepheid.

Patient Support and Services

• Rapid diagnostic screening services, educational resources, and comprehensive technical assistance are provided in the patient support and services of the qPCR instruments.
• Key players: Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics.

Market Trends

The global qPCR instruments market size was estimated at USD 6.8 billion in 2025 and is predicted to increase from USD 7.41 billion in 2026 to approximately USD 15.95 billion by 2035, expanding at a CAGR of 8.9% from 2026 to 2035. The rise in disease burden and growing R&D activities are increasing the use of qPCR instruments. Growing applications, expanding point-of-care testing trends, government initiatives, and new product launches are also enhancing the market growth.